- Home
- HNVR vs STXS Comparison
HNVR vs STXS Comparison
Compare HNVR & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNVR
- STXS
- Stock Information
- Founded
- HNVR 2008
- STXS 1990
- Country
- HNVR United States
- STXS United States
- Employees
- HNVR N/A
- STXS N/A
- Industry
- HNVR Commercial Banks
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HNVR Finance
- STXS Health Care
- Exchange
- HNVR Nasdaq
- STXS Nasdaq
- Market Cap
- HNVR 143.6M
- STXS 151.3M
- IPO Year
- HNVR 2022
- STXS 2004
- Fundamental
- Price
- HNVR $23.11
- STXS $2.14
- Analyst Decision
- HNVR Buy
- STXS
- Analyst Count
- HNVR 1
- STXS 0
- Target Price
- HNVR $22.00
- STXS N/A
- AVG Volume (30 Days)
- HNVR 27.4K
- STXS 282.8K
- Earning Date
- HNVR 04-23-2025
- STXS 05-12-2025
- Dividend Yield
- HNVR 1.73%
- STXS N/A
- EPS Growth
- HNVR N/A
- STXS N/A
- EPS
- HNVR 1.30
- STXS N/A
- Revenue
- HNVR $65,041,000.00
- STXS $26,918,000.00
- Revenue This Year
- HNVR N/A
- STXS $25.90
- Revenue Next Year
- HNVR $15.80
- STXS $60.57
- P/E Ratio
- HNVR $17.77
- STXS N/A
- Revenue Growth
- HNVR 1.13
- STXS 0.55
- 52 Week Low
- HNVR $15.92
- STXS $1.54
- 52 Week High
- HNVR $27.14
- STXS $2.72
- Technical
- Relative Strength Index (RSI)
- HNVR 56.86
- STXS 63.79
- Support Level
- HNVR $22.37
- STXS $1.93
- Resistance Level
- HNVR $23.94
- STXS $2.07
- Average True Range (ATR)
- HNVR 0.77
- STXS 0.09
- MACD
- HNVR 0.12
- STXS 0.02
- Stochastic Oscillator
- HNVR 74.93
- STXS 75.79
About HNVR Hanover Bancorp Inc.
Hanover Bancorp Inc is a United States-based banking company. It offers a full range of financial services and employs a complete suite of consumer and commercial banking products and services, including multi-family and commercial mortgages, residential loans, business loans, and lines of credit.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.